Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours

BACKGROUND: The aim of this prospective study was to examine whether discontinuation of proton pump inhibitors (PPIs) or replacement by H(2)-receptor antagonists (H2RA) resulted in a decrease of chromogranin A (CgA) levels in 196 patients with well-differentiated neuroendocrine tumours (NETs). METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Korse, C M, Muller, M, Taal, B G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208502/
https://www.ncbi.nlm.nih.gov/pubmed/21989216
http://dx.doi.org/10.1038/bjc.2011.380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208502/
https://www.ncbi.nlm.nih.gov/pubmed/21989216
http://dx.doi.org/10.1038/bjc.2011.380

Ejemplares similares